Immune checkpoint inhibitors (ICIs), such as programmed death 1 (PD-1)/programmed death ligand 1 (PD-L1) inhibitors have made a significant breakthrough in lung cancer treatment (1–3). The gene discussed is CD274; the disease is lung carcinoma.